Ticker brief
PM PHILIP MORRIS INTERNATIONAL
Consumer, Non-cyclical · Agriculture
last close
$182.27
1 day
+2.6%
14 days
+2.2%
mkt cap
$284.1B
signals 14d
29
authors 14d
23
Sentiment — last 14 days
daily mean sentiment, 2026-06-19 → 2026-07-02 · now +0.45 (−1 bearish … +1 bullish)
Who spoke23
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @tobaccoinsider | C | +0.04 | 4 | +0.31 |
| @lwsresearch | C | +0.51 | 2 | +0.25 |
| @WSJ | A | +0.51 | 2 | +0.50 |
| @EmmanuelInvest | C | -1.12 | 2 | +0.40 |
| @Ross__Hendricks | A | -0.78 | 1 | +0.40 |
| @ianlopuch | C | -0.20 | 1 | +0.45 |
| @SPXplays | C | -1.51 | 1 | +0.65 |
| @tradfi | C | +1.25 | 1 | +0.50 |
| @negligible_cap | B | -1.49 | 1 | +0.50 |
| @wallstengine | B | +0.82 | 1 | +0.30 |
| @tenet_research | C | -2.08 | 1 | +0.50 |
| @PolymarketMoney | C | -1.00 | 1 | +0.45 |
| @CNBC | C | -1.91 | 1 | +0.50 |
| @PolarizingLit | C | +0.26 | 1 | +0.00 |
| @unusual_whales | C | · | 1 | +0.50 |
| @Financhle | C | · | 1 | +0.80 |
| @faststocknewss | C | -2.02 | 1 | +0.50 |
| @newsinvesting | C | · | 1 | +0.50 |
| @BarbarianCap | B | +1.88 | 1 | +0.50 |
| @OpenOutcrier | C | · | 1 | +0.50 |
| @InvestmentCamel | C | -0.35 | 1 | +0.50 |
| @Benzinga | C | -2.47 | 1 | +0.50 |
| @MacroAlphaHQ | A | +1.15 | 1 | +0.55 |
Recent signals29of 29 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @EmmanuelInvest | +0.40 | UBS raises Philip Morris PT to $182 from $168 on ZYN momentum. | — | tweet ↗ |
| 2026-07-02 | @MacroAlphaHQ | +0.55 | FDA blessed Zyn as safer than cigarettes, creating a positive regulatory catalyst for PM. | — | tweet ↗ |
| 2026-07-02 | @EmmanuelInvest | +0.40 | UBS raises Philip Morris PT to $182 from $168. | — | tweet ↗ |
| 2026-07-01 | @Benzinga | +0.50 | FDA authorizes lower disease risk claim for select Philip Morris Zyn nicotine pouches. | +2.6% | tweet ↗ |
| 2026-07-01 | @InvestmentCamel | +0.50 | FDA approved differentiated warning language for ZYN; PM received buy recommendations. | +2.6% | tweet ↗ |
| 2026-07-01 | @OpenOutcrier | +0.50 | FDA lets Philip Morris market Zyn pouches as less harmful than cigarettes. | +2.6% | tweet ↗ |
| 2026-07-01 | @tobaccoinsider | -0.25 | PMI accused of using AI to generate consumer responses opposing EU nicotine rules; company denies wrongdoing. | +2.6% | tweet ↗ |
| 2026-06-30 | @BarbarianCap | +0.50 | FDA says Zyn can market itself as less harmful than cigarettes. | +0.8% | tweet ↗ |
| 2026-06-30 | @newsinvesting | +0.50 | FDA clears Philip Morris Zyn marketing as lower cancer risk than cigarettes. | +0.8% | tweet ↗ |
| 2026-06-30 | @faststocknewss | +0.50 | FDA authorized Philip Morris to market Zyn as lower risk than cigarettes for five years. | +0.8% | tweet ↗ |
| 2026-06-30 | @lwsresearch | +0.50 | FDA would allow PM's Zyn pouches to be marketed as less harmful, per Axios. | +0.8% | tweet ↗ |
| 2026-06-30 | @Financhle | +0.80 | Author explicitly says gigalong Philip Morris. | +0.8% | tweet ↗ |
| 2026-06-30 | @unusual_whales | +0.50 | FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes. | +0.8% | tweet ↗ |
| 2026-06-30 | @PolarizingLit | +0.00 | States not holding PM but using, with unclear stance. | +0.8% | tweet ↗ |
| 2026-06-30 | @WSJ | +0.50 | Federal regulator gives Philip Morris International a win for nicotine pouches. | +0.8% | tweet ↗ |
| 2026-06-30 | @WSJ | +0.50 | Federal regulator gives Philip Morris International a win for nicotine pouches. | +0.8% | tweet ↗ |
| 2026-06-30 | @CNBC | +0.50 | FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes. | +0.8% | tweet ↗ |
| 2026-06-30 | @tobaccoinsider | +0.50 | 20 ZYN products received modified risk granted orders across two strengths and ten flavors. | +0.8% | tweet ↗ |
| 2026-06-30 | @tobaccoinsider | +0.50 | FDA MRTP authorization allows 20 ZYN products to market lower-risk claim versus cigarettes. | +0.8% | tweet ↗ |
| 2026-06-30 | @tobaccoinsider | +0.50 | FDA authorized 20 ZYN nicotine pouch products to market a specific modified-risk claim. | +0.8% | tweet ↗ |
| 2026-06-30 | @PolymarketMoney | +0.45 | FDA reportedly to allow Zyn marketing as less harmful; Zyn owner ticker inferred. | +0.8% | tweet ↗ |
| 2026-06-30 | @tenet_research | +0.50 | FDA issues modified risk tobacco product orders for 20 ZYN nicotine pouch products. | +0.8% | tweet ↗ |
| 2026-06-30 | @wallstengine | +0.30 | Axios says FDA expected to allow Zyn pouches to be marketed as less harmful than cigarettes. | +0.8% | tweet ↗ |
| 2026-06-30 | @negligible_cap | +0.50 | Axios reports FDA allows Zyn to market pouches as less harmful than cigarettes. | +0.8% | tweet ↗ |
| 2026-06-30 | @tradfi | +0.50 | Axios reports FDA allows Zyn to sell pouches on health benefits. | +0.8% | tweet ↗ |
| 2026-06-29 | @lwsresearch | +0.00 | BAT will cut and outsource jobs for AI transformation and cost savings. | -0.3% | tweet ↗ |
| 2026-06-25 | @SPXplays | +0.65 | long PM under SPY 730 — States calls on cigarette smokers under SPY 730 and explicitly says long PM. | +1.9% | tweet ↗ |
| 2026-06-23 | @ianlopuch | +0.45 | Discloses long MO, PM, and BTI and positive view during volatile markets. | +2.0% | tweet ↗ |
| 2026-06-19 | @Ross__Hendricks | +0.40 | Discloses long energy and tobacco stocks and says Mag-7 have been good shorts YTD. | +2.2% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.